![Next-Generation Immune Monitoring in Immuno-oncology Trials](https://www.precisionformedicine.com/hs-fs/hubfs/PFM%20-%202024%20New%20blog%20images/Immune%20Monitoring.webp?width=396&height=224&name=Immune%20Monitoring.webp)
![Ulrich, Hoffmueller Avatar](https://www.precisionformedicine.com/hs-fs/hubfs/PfM%20Website/Headshots/Headshots%20no%20background/Ulrich%20Hoffmueller.webp?width=100&height=100&name=Ulrich%20Hoffmueller.webp)
Ulrich Hoffmueller
Dr. Hoffmueller is a veteran biochemist, industry expert, and cofounder of Epiontis. He holds a Master’s in Biochemistry from Humboldt University, a PhD from the Charité University Clinic, receiving the Charité Research Award, and an MBA from the Berlin School of Economics and Law, Berlin, Germany.
-
Read: Next-Generation Immune Monitoring in Immuno-oncology Trials Next-Generation Immune Monitoring in Immuno-oncology Trials
Loading...
You've reach the end